Otsuka, Lundbeck Fail to Sway Adcomm on Rexulti Combo for PTSD

Otsuka and Lundbeck’s data are insufficient to establish significant efficacy of Rexulti plus sertraline in PTSD, according to the FDA’s outside experts.

Scroll to Top